“…[6,22,23] Deep and detailed investigations by Trauner, Decker, Szymanski and many other groups demon-strate the potency of such approach for photopharmacology. [8,[24][25][26] Special attention of photopharmacology is focused on the design of photoswitchable inhibitors of two important esterases -acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). These esterases are involved in the hydrolysis of the acetylcholine neurotransmitter and are connected with heavy human disorders -Alzheimer's disease, memory disorders, skin diseases (psoriasis, epithelial cell injuries, vitiligo, atopic dermatitis, etc).…”